AAAAAA

   
Results: 1-25 | 26-30 |
Results: 26-30/30

Authors: Yokosuka, O Kojima, H Imazeki, F Tagawa, M Saisho, H Tamatsukuri, S Omata, M
Citation: O. Yokosuka et al., Spontaneous negativation of serum hepatitis C virus RNA is a rare event intype C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years, J HEPATOL, 31(3), 1999, pp. 394-399

Authors: Kojima, H Yokosuka, O Kato, N Shiina, S Imazeki, F Saisho, H Shiratori, Y Omata, M
Citation: H. Kojima et al., Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens, J HEPATOL, 31(3), 1999, pp. 514-520

Authors: Kawai, S Yokosuka, O Kanda, T Imazeki, F Maru, Y Saisho, H
Citation: S. Kawai et al., Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay, J MED VIROL, 58(2), 1999, pp. 121-126

Authors: Honda, A Yokosuka, O Ehata, T Tagawa, M Imazeki, F Saisho, H
Citation: A. Honda et al., Detection of mutations in the enhancer 2/core promoter region of hepatitisB virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status, J MED VIROL, 57(4), 1999, pp. 337-344

Authors: Yoshida, H Shiratori, Y Moriyama, M Arakawa, Y Ide, T Sata, M Inoue, O Yano, M Tanaka, M Fujiyama, S Nishiguchi, S Kuroki, T Imazeki, F Yokosuka, O Kinoyama, S Yamada, G Omata, M
Citation: H. Yoshida et al., Interferon therapy reduces the risk for hepatocellular carcinoma: Nationalsurveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan, ANN INT MED, 131(3), 1999, pp. 174
Risultati: 1-25 | 26-30 |